Clinical trial

COG-PSYCHO : Social Cognition and Psychotic Characteristics: Genetic and Phenomic Approach

NCT04928053

Drugs and interventions used in this trial

1 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

GENETIC · Unmapped registry intervention ocytocine dosage and genetic analyse Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

COG-PSYCHO : Social Cognition and Psychotic Characteristics: Genetic and Phenomic Approach

Design: INTERVENTIONAL · Status: UNKNOWN · Phase: NA

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusUNKNOWN

Study typeINTERVENTIONAL

Start date2019-02-04

PhaseNA

Conditions

Social Cognition of Schizophrenia, Bipolas or Depressed Patientsunresolved

Interventions

ocytocine dosage and genetic analyseGENETIC

Sponsors & collaborators

Assistance Publique - Hôpitaux de Parislead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT04928053 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.